CollPlant Biotechnologies Ltd (CLGN) KPIs and segments
Close on Nov 11, 2026Market cap –P/E –Yield –
KPIs & segments
Operating metrics and segments that drive CollPlant Biotechnologies's business
CollPlant Biotechnologies's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|
Revenues from milestones($M) | 10 | ||||||||
Revenues from the Sales of Goods($M) | 0.18 | 0.25 | 0.18 | ||||||
United States($M) | 10.2 | 0.04 | 0.19 | 0.79 | 0.55 | ||||
North America($M) | 0.16 | 0.24 | |||||||
Europe and others($M) | 0.02 | 0.01 | 0.02 | 0.03 | 0.50 | 0.03 | 0.05 | 0.05 | |
Earlier reporting (last reported 2024)1 | |||||||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-03-26.
See a number that looks wrong?